BEA-005

NC1=NC(=O)N(C=C1)[C@H]2C[C@H](CO)[C@@H](CO)O2

InChIKey=WZGBNAXNHRMYLG-ZXFLCMHBSA-N

InChI=1S/C10H15N3O4/c11-8-1-2-13(10(16)12-8)9-3-6(4-14)7(5-15)17-9/h1-2,6-7,9,14-15H,3-5H2,(H2,11,12,16)/t6-,7-,9-/m1/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
Comparative studies of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues.	1990	1964029
Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005.	1997 Feb	9030361
Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2',3'-dideoxy-3'-C-(hydroxymethyl)-beta-D-erythropentofuranosyl] cytosine.	1998 May	9629471

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:47:49 GMT 2023` Edited by `admin` on `Sat Dec 16 09:47:49 GMT 2023`
Record UNII	C7BPP68MLT
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

BEA-005

Common Name

English

CYTIDINE, 2',3'-DIDEOXY-3'-(HYDROXYMETHYL)-

Systematic Name

English

Code System Code Type Description

PUBCHEM

451819

Created by admin on Sat Dec 16 09:47:50 GMT 2023 , Edited by admin on Sat Dec 16 09:47:50 GMT 2023

PRIMARY

EPA CompTox

DTXSID60157443

Created by admin on Sat Dec 16 09:47:50 GMT 2023 , Edited by admin on Sat Dec 16 09:47:50 GMT 2023

PRIMARY

FDA UNII

C7BPP68MLT

Created by admin on Sat Dec 16 09:47:50 GMT 2023 , Edited by admin on Sat Dec 16 09:47:50 GMT 2023

PRIMARY

CAS

132235-73-5

Created by admin on Sat Dec 16 09:47:50 GMT 2023 , Edited by admin on Sat Dec 16 09:47:50 GMT 2023

PRIMARY

Related Record Type Details


					C7BPP68MLT

BEA-005

ACTIVE MOIETY